Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

NETWORK 3OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 552Colorectal Neoplasms 246Neoplasms 232Prostatic Neoplasms 221Carcinoma, Non-Small-Cell Lung 196Stomach Neoplasms 153Leukemia, Myeloid, Acute 149Carcinoma, Hepatocellular 147Lung Neoplasms 137Rectal Neoplasms 135Multiple Myeloma 133Nasopharyngeal Carcinoma 112Colonic Neoplasms 106Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Lymphoma 85Uterine Cervical Neoplasms 83Pancreatic Neoplasms 82Lymphoma, Large B-Cell, Diffuse 79Ovarian Neoplasms 78Leukemia 78Head and Neck Neoplasms 77Esophageal Neoplasms 74Lymphoma, Follicular 72Brain Neoplasms 70Squamous Cell Carcinoma of Head and Neck 65Recurrence 64Leukemia, Lymphocytic, Chronic, B-Cell 59Lymphoma, Non-Hodgkin 58Pain 56

Interventions

Vitamin B Complex 1Vacuum Curettage 1Methotrexate 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Hydatidiform Mole × Clear all
NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown
150 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

NCT01984099 2020-04-17

RCT on the Efficacy of Methotrexate for the Prevention of GTD

University of the Philippines

Phase 3 Completed
99 enrolled

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡